Your session is about to expire
ā Back to Search
Mobile Video Interpretation for Limited English Proficiency (mVOCAL Trial)
N/A
Waitlist Available
Research Sponsored by Seattle Children's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 9 months
Awards & highlights
mVOCAL Trial Summary
This trial will test strategies to improve communication between doctors and patients with limited English proficiency, leading to better, safer medical care and reducing disparities.
Who is the study for?
This trial is for patients and families who prefer to communicate in a language other than English or sign language during medical care. They must visit a participating clinic, have an acute concern like a sore throat, and if under 18, be with a parent or guardian. Providers need to work at least 40% full-time and require interpretation often.Check my eligibility
What is being tested?
The study tests two strategies: web-based educational modules for providers and mobile video interpreting (mVI) access for non-English speakers. It aims to improve the use of professional interpreters in primary care, hoping this will lead to safer and more equitable healthcare.See study design
What are the potential side effects?
There are no traditional side effects as this isn't testing medication; however, there may be technical issues with mVI or challenges adapting to new communication methods that could affect patient-provider interactions.
mVOCAL Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at 9 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 9 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Interpreter Use per Clinic Visit with Patient with LOE
Secondary outcome measures
Patient/Parent Comprehension
mVOCAL Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Mobile video interpreting access (mVI)Experimental Treatment1 Intervention
This strategy will involve giving assigned providers access to mobile video interpreting (mVI) on a personal device, installation and support as needed, a tip sheet, and an extra charger, optional shock-resistant case, disposable antimicrobial sleeves, and a positioning stand to support use of their personal device for clinical care. mVI-assigned providers can opt for a study-issued smartphone in lieu of using their own. Access to mVI is achieved by downloading the application from the relevant location (e.g., Apple App Store), then entering an access code that links to a billing account. The study staff would then demonstrate use and answer questions. Technical support will be offered in-person following randomization; we will then email mVI-assigned providers weekly for the first month, then monthly, to offer additional support. A tip-sheet will be sent via email during the first week of the study that will include mVI instructions and best-practices.
Group II: Web based educational modulesActive Control1 Intervention
This strategy will consist of 6 web-based modules, clinic-specific interpreter access information, and 4 booster modules, all delivered via the internet. The online modules will cover 5 topics: 1) the importance and fundamentals of good communication; 2) the importance of professional interpreter use and disparities for LEP populations; 3) how to use an interpreter effectively; 4) what to do when the encounter is not going well; and 5) special challenges and solutions related to remote interpreter use. Modules will be interactive, with tailoring to the learner, and each will be <15 minutes long. All modules will be available at once, but assigned providers will be prompted to view a new one each week. Every month for months 3-6 after randomization, a booster module will be released. The brief (<10 min) boosters will review crucial points from initial modules and feature video vignettes. Providers will be reminded to view these weekly until they are complete.
Find a Location
Who is running the clinical trial?
Seattle Children's HospitalLead Sponsor
301 Previous Clinical Trials
5,210,308 Total Patients Enrolled
1 Trials studying Limited English Proficiency
83 Patients Enrolled for Limited English Proficiency
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I prefer a language other than sign language and will visit the clinic with an enrolled provider. If I'm under 18, I'll be with a parent or guardian.My preferred language is one of the top 7 non-English languages, and I visited the clinic for an acute issue.My preferred language for care is not English or sign language, and I have visited the clinic during the study.
Research Study Groups:
This trial has the following groups:- Group 1: Web based educational modules
- Group 2: Mobile video interpreting access (mVI)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment currently open for this research trial?
"According to data on clinicaltrials.gov, this trial is no longer actively searching for participants as it has not been updated since October 21st 2022. Despite this, two other trials are presently accepting patients at the moment."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger